• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Adamis Pharmaceuticals Corporation (ADMP)

    -NasdaqCM
    5.23 Up 0.06(1.16%) Dec 26, 3:57PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2014Mar 31, 2013Mar 31, 2012
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development1,006  1,209  2,166  
    Selling General and Administrative3,389  2,008  2,649  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (4,395) (3,218) (4,815)
    Income from Continuing Operations
    Total Other Income/Expenses Net4,866  (1,513)5  
    Earnings Before Interest And Taxes470  (4,731)(4,810)
    Interest Expense8,626  2,334  35  
    Income Before Tax(8,156)(7,065)(4,845)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(8,156)(7,065)(4,845)
    Non-recurring Events
    Discontinued Operations -  (130)(70)
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (8,156) (7,195) (4,915)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (8,156) (7,195) (4,915)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.